logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Opinion on Emerging Drugs cover

Expert Opinion on Emerging Drugs

IF2.7
Papers53
Citations897
Journal Papers 49
Publication Date
delete
Emerging therapies for pericarditis: from anti-IL-1 agents to novel therapeutic options
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-10-03
delete0
deleteOAAI
deleteMassimo Imazio; Valentino Collini; Francesco Venturelli; Maria Cristina Tomat; Giulio Savonitto; Davide Stolfo
deleteShare
deleteSave
Emerging drugs for diabetic macular edema: an update
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-10-01
delete0
PREAI
deleteCharles Zhang; Sinan Ersan; Abdullah Virk; Alexander E. Higgins; Ingrid U. Scott; Harry W. Flynn Jr
deleteShare
deleteSave
Targeted oral peptide therapy for inflammatory bowel disease: focus on the IL-23 receptor antagonist icotrokinra
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-09-28
delete0
deleteOAAI
deleteDaniele Noviello; Flavio Caprioli; Nurulamin M. Noor
deleteShare
deleteSave
Emerging drugs for the treatment of gastrointestinal stromal tumors: a spotlight on bezuclastinib and the evolving treatment landscape
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-09-26
delete0
deleteOAAI
deleteJavier Pozas; Andrea Napolitano; Robin L Jones
deleteShare
deleteSave
Recent advances in hidradenitis suppurativa therapeutics: a focus on existing and future medical therapeutics
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-09-09
delete0
PREAI
deleteCamila R. Marquez; Aditya Joshi; Lauren Gawey; Stacey N. Giuffre; Crystal Khem; Jennifer L. Hsiao; Vivian Y. Shi
deleteShare
deleteSave
Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-07-26
delete0
PREAI
deleteSarah Ottum; Namrata Sethi; Cem Demirkiran; Orazio De Tommasi; Alessandro D. Santin
deleteShare
deleteSave
Drug discovery progress in targeting the renin–angiotensin–aldosterone system for heart failure
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-07-21
delete0
deleteOAAI
deleteDiksha Choudhary; Nisha Bansal; Bhupinder Kumar
deleteShare
deleteSave
Emerging biological drugs for the treatment of patients with metastatic HER2+ gastroesophageal adenocarcinomas
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-07-20
delete0
PREAI
deleteJane E. Rogers; Ashley Horak; Alicia Kroll; Jaffer A. Ajani
deleteShare
deleteSave
At the forefront of gene-based therapies in Dravet syndrome
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-07-08
delete0
deleteOAAI
deleteAntonella Riva; Sara Di Gioacchino; Greta Volpedo; Beatrice Risso; Antonella De Lillo; Federico Zara; Antonio Falace; Pasquale Striano
deleteShare
deleteSave
Sigma 1 receptor agonists: the new trend or an emerging therapeutic option?
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-29
delete0
deleteOAAI
deleteTangui Maurice
deleteShare
deleteSave
Obefazimod (ABX464) for moderate-to-severe Crohn’s disease: clinical development of a novel oral therapeutic approach
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-29
delete0
deleteOAAI
deleteSailish Honap; Axel Dignass; Vipul Jairath; Fernando Magro; Silvio Danese; Laurent Peyrin-Biroulet
deleteShare
deleteSave
Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer’s disease
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-22
delete0
PREAI
deleteMadia Lozupone; Vittorio Dibello; Rodolfo Sardone; Roberta Zupo; Fabio Castellana; Ilaria Bortone; Luisa Lampignano; Michela Di Matteo; Giuseppe Moramarco; Flora Dellegrazie; Antonio Daniele; Vincenzo Solfrizzi; Francesco Panza
deleteShare
deleteSave
Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-22
delete0
PREAI
deleteCarolyn J. Wang; Clarus Leung; Don D. Sin
deleteShare
deleteSave
Acute management of adult MOG antibody–associated disease: therapeutic choices and clinical outcomes
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-18
delete0
deleteOAAI
deleteEdgar Carnero Contentti; Eoin P. Flanagan; Ethel Ciampi
deleteShare
deleteSave
Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-16
delete0
deleteOAAI
deleteLanfranco Pellesi; Damiana Scuteri; Andrea Burgalassi; Alberto Chiarugi; Paolo Martelletti
deleteShare
deleteSave
Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-07
delete0
PREAI
deleteCristina Lanzotti; Fabrizio Fanizzi; Ferdinando D’Amico; Alessandra Zilli; Federica Furfaro; Mariangela Allocca; Virginia Solitano; Clelia Cicerone; Sara Massironi; Tommaso Lorenzo Parigi; Laurent Peyrin-Biroulet; Silvio Danese
deleteShare
deleteSave
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-05
delete0
PREAI
deleteDaniel Neureiter; Dino Bekric; Christian Mayr; Tobias Kiesslich; Matthias Ocker
deleteShare
deleteSave
Emerging pharmacotherapies in Gaucher disease
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-05-19
delete0
deleteOAAI
deleteGregory M. Pastores
deleteShare
deleteSave
Potassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground?
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-05-19
delete0
PREAI
deleteCristiana Pelorosso; Simona Balestrini; Renzo Guerrini
deleteShare
deleteSave
Phase II and III trials in systemic sclerosis: from recent FDA approvals to emerging applications of cellular therapies
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-05-18
delete0
deleteOAAI
deleteAlain Lescoat; Eisha Naveed; Dinesh Khanna
deleteShare
deleteSave